On Tuesday, December 30, 2025, the Drug Enforcement Administration (“DEA”) and the Department of Health and Human Services (“HHS,” and together with the DEA, the “Agencies”) issued a fourth temporary rule (the “Fourth Temporary Rule”) extending the COVID-19-era telemedicine flexibilities for prescribing Schedule II–V controlled substances through December 31, 2026. The extension allows DEA-registered practitioners... READ MORE
DEA and HHS Announce Fourth Extension of COVID-Era Telemedicine Flexibilities for Controlled Substance Prescribing
Posted on December 30, 2025 in Health Law News
Published by: Hall Render
